The US Chronic Disease Management Market is projected to reach USD 2.6 billion in 2025 and grow to USD 8.2 billion by 2034 at a CAGR of 13.5%. Rising prevalence of chronic conditions, increasing aging population, and growing adoption of digital healthcare technologies are driving market growth. Healthcare providers are increasingly using remote patient monitoring, telehealth platforms, and AI-based analytics to manage chronic diseases effectively. These technologies enable continuous patient monitoring, improved treatment adherence, and better healthcare outcomes. Supportive regulatory frameworks and evolving healthcare reimbursement policies are further supporting the adoption of chronic disease management solutions. The increasing focus on value-based care models and patient-centered healthcare systems is expected to strengthen market expansion in the coming years.

The US Chronic Disease Management Market is projected to reach USD 2.6 billion in 2025, driven by the high and rising prevalence of chronic conditions, an aging population, and a strong shift toward value-based care and digital health integration nationwide. The market is expected to expand at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2034, reaching a projected value of USD 8.2 billion by 2034.

Growth is fueled by the widespread adoption of remote patient monitoring (RPM) and telehealth, strategic integration of artificial intelligence (AI) and predictive analytics, evolving regulatory and reimbursement frameworks (such as CMS guidelines and FDA digital health policies), and increasing demand for cost-effective, patient-centered care models. Furthermore, expanding applications across Diabetes, Cardiovascular Diseases (CVD), and Chronic Respiratory Diseases, alongside the push for interoperable solutions and comprehensive population health management, are expected to significantly accelerate market expansion.

The US chronic care landscape is rapidly transitioning from reactive, episodic care to continuous, data-driven management ecosystems. A pivotal trend is the strategic convergence of disease-specific digital therapeutics and telehealth, where CDM platforms are evolving into integrated care delivery hubs. These hubs enable personalized monitoring, virtual visits, and automated interventions, which are essential for meeting quality metrics and patient self-management goals under value-based reimbursement models.

This integration empowers proactive health management and provides real-time clinical decision support for complex conditions like heart failure and COPD. Concurrently, CDM solution providers are embedding sophisticated analytics and clinical decision support (CDS) tools, offering risk stratification and personalized care pathway automation as core features, making data intelligence central to the chronic care value chain. The fusion of AI with population health platforms is also gaining prominence, optimizing resource allocation and preemptively identifying high-risk patient cohorts across diverse US healthcare settings.